Stock Analysis on Net
Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

Common-Size Balance Sheet: Assets
Quarterly Data

Pfizer Inc., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 31, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents 1.26 1.46 1.20 1.11 0.21 0.67 0.91 1.34 1.07 1.10 1.40 1.11 1.16 0.89 1.01 1.29 0.78 1.63 1.14 1.25
Short-term investments 4.34 19.08 19.15 9.10 11.32 17.92 16.14 11.66 16.05 15.48 11.37 7.49 6.77 4.98 5.38 4.93 5.09 3.70 7.12 6.23
Restricted short-term investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.38 6.41 0.00 0.00 0.00 0.00 0.00
Trade accounts receivable, less allowance for doubtful accounts 4.93 5.16 4.65 6.29 5.55 8.27 7.76 7.19 6.33 6.64 6.23 6.21 5.14 5.59 5.13 5.94 5.21 5.54 6.27 6.18
Inventories 4.50 4.75 4.68 4.88 4.55 4.89 5.35 5.43 4.99 4.82 5.27 5.35 5.22 5.19 4.81 5.06 4.95 4.82 5.27 5.17
Current tax assets 1.76 1.82 1.45 1.61 1.81 1.31 1.32 1.70 2.35 2.16 2.21 2.15 2.12 2.23 1.93 2.01 2.00 2.19 2.38 2.32
Other current assets 2.34 2.15 2.19 2.62 2.54 3.16 3.06 2.29 2.10 2.12 2.25 2.58 2.34 1.41 1.41 1.65 1.57 1.75 7.95 8.01
Current assets 19.13% 34.42% 33.31% 25.60% 25.99% 36.22% 34.55% 29.60% 32.89% 32.31% 28.73% 24.89% 22.74% 26.67% 26.09% 20.88% 19.59% 19.63% 30.14% 29.14%
Equity-method investments 5.14 5.13 5.19 5.71 5.59 5.06 7.58 8.70 9.08 9.12 9.77 10.41 10.93 8.91 8.75 9.33 10.23 9.39 0.00 0.00
Long-term investments 1.65 1.49 1.66 1.82 2.05 2.09 2.13 2.58 2.78 2.93 2.55 2.33 2.21 1.71 1.77 1.62 1.80 1.60 1.86 1.84
Property, plant and equipment, less accumulated depreciation 8.36 8.31 7.94 8.72 8.25 7.94 7.81 8.22 8.20 8.06 8.37 8.82 9.01 8.05 7.93 8.44 8.34 8.04 8.66 8.66
Identifiable intangible assets 28.65 18.71 18.81 21.47 21.99 14.48 14.88 16.22 13.86 14.68 16.08 17.61 18.46 17.28 18.85 20.72 21.12 22.88 21.14 21.90
Goodwill 29.93 23.96 23.42 26.31 26.05 24.92 25.55 27.31 27.12 27.62 29.35 31.35 32.15 33.47 32.85 35.17 35.02 34.42 34.16 34.41
Noncurrent deferred tax assets and other noncurrent tax assets 1.64 3.88 3.75 3.73 3.39 3.67 3.59 3.08 1.84 1.54 1.59 1.60 1.55 1.48 1.33 1.33 1.25 1.16 1.24 1.25
Other noncurrent assets 5.51 4.10 5.92 6.63 6.68 5.60 3.92 4.29 4.23 3.74 3.56 2.99 2.96 2.43 2.43 2.50 2.66 2.89 2.81 2.79
Noncurrent assets 80.87% 65.58% 66.69% 74.40% 74.01% 63.78% 65.45% 70.40% 67.11% 67.69% 71.27% 75.11% 77.26% 73.33% 73.91% 79.12% 80.41% 80.37% 69.86% 70.86%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-27), 10-Q (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-29), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Pfizer Inc. current assets as a percentage of total assets increased from Q2 2023 to Q3 2023 but then decreased significantly from Q3 2023 to Q4 2023.
Property, plant and equipment, less accumulated depreciation Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Pfizer Inc. property, plant and equipment, less accumulated depreciation as a percentage of total assets increased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Pfizer Inc. noncurrent assets as a percentage of total assets decreased from Q2 2023 to Q3 2023 but then increased from Q3 2023 to Q4 2023 exceeding Q2 2023 level.